FeesSafety
Pluang+

NCI grants $2.9M to study RedHill's opaganib with CAR T-cell therapy for multiple myeloma.

Market News
19 Oct 2026, 15:00 WIB
PRNewsWire
View Source
Bullish
NCI grants $2.9M to study RedHill's opaganib with CAR T-cell therapy for multiple myeloma.

The National Cancer Institute awarded $2.9 million to the University of Oklahoma to fund clinical trials testing RedHill Biopharma's investigational drug opaganib combined with CAR T-cell therapy for ultra-high-risk multiple myeloma. The trials aim to evaluate safety and preliminary effectiveness, potentially improving immune cell cancer-fighting ability. This study could lead to longer-lasting treatment responses for patients with poor prognosis. RedHill will supply opaganib, while the University of Oklahoma will manufacture CAR T cells on campus, reducing costs and time.

The $2.9 million NCI grant for RedHill's opaganib and CAR T-cell combination in multiple myeloma is the subject, with Pluang's Health sector data providing context. As of Oct 19, 2026 18:01 WIB, out of 150 priced Health-sector US stocks tradable on Pluang, 73 rose and 47 fell. Notable movers include AMLX at USD 26.86 (+1.97%), RLAY at USD 16.59 (+1.90%), and BFLY at USD 7.38 (+1.86%).

More News

Etsy edges out Advance Auto Parts as the preferred retail stock for 2027 due to stronger profitability and growth.

Etsy edges out Advance Auto Parts as the preferred retail stock for 2027 due to stronger profitability and growth.

Investors face a choice between Advance Auto Parts, a traditional automotive parts retailer facing a challenging turnaround, and Etsy, a digital marketplace with strong profitability and growth. Advance Auto Parts reported declining revenue and mixed...

Market News
Neutral
1 hour ago
Micron and Sandisk lead the AI-driven memory market race with strong growth but different risk profiles.

Micron and Sandisk lead the AI-driven memory market race with strong growth but different risk profiles.

Micron Technology and Sandisk are key players in the booming memory market driven by AI demand. Micron offers a broad range of memory products with massive scale and strong cash flow, but faces risks from customer concentration and market cyclicality...

Market News
Bullish
1 hour ago
Palantir shares soar 167% in 2023 but now trade at a high 53x sales in 2026 amid strong growth.

Palantir shares soar 167% in 2023 but now trade at a high 53x sales in 2026 amid strong growth.

Palantir's stock surged 167% in 2023 after posting its first positive GAAP net income and modest revenue growth of 17%. However, by 2026, the shares trade at about 53 times sales, reflecting a very high valuation despite strong revenue growth nearing...

Market News
Neutral
1 hour ago
SpaceX catches Starship upper stage, setting space monopoly path amid rivals' failures.

SpaceX catches Starship upper stage, setting space monopoly path amid rivals' failures.

SpaceX achieved a major milestone by successfully catching the upper stage of its Starship rocket using mechanical arms, marking a significant advance over competitors. This success comes as rivals like United Launch Alliance and Blue Origin face set...

Market News
Bullish
1 hour ago
Coinbase stock drops 64% from 52-week high amid ongoing crypto market downturn.

Coinbase stock drops 64% from 52-week high amid ongoing crypto market downturn.

Coinbase's stock has fallen about 64% from its 52-week high due to a prolonged crypto winter and declining user activity. The company saw a 29% revenue drop and a 62% plunge in adjusted EBITDA in early 2026, driven by rising interest rates, competiti...

Market News
Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App